[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Pages 56927-56928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20012]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-19-2022]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Authorization 
of Production Activity; AbbVie Ltd. (Pharmaceutical Products), 
Barceloneta, Puerto Rico

    On May 13, 2022, AbbVie Ltd., submitted a notification of proposed 
production activity to the FTZ Board for its facility within Subzone 
7I, in Barceloneta, Puerto Rico.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 30448, May 19, 2022). On 
September 12, 2022, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to

[[Page 56928]]

the FTZ Act and the FTZ Board's regulations, including section 400.14.

    Dated: September 12, 2022.
Christopher Kemp,
Acting Executive Secretary.
[FR Doc. 2022-20012 Filed 9-15-22; 8:45 am]
BILLING CODE 3510-DS-P